Dangerous Drug Update: FDA Official Criticizes Clinical Trials, Details Dangers of Avandia
Avandia, also known as rosiglitazone, was dealt a serious blow Friday when an FDA official revealed that over a dozen individuals taking Avandia and suffering from serious heart problems were not counted in a study that proclaimed Avandia as safe.
The FDA reviewer, Dr. Thomas Marciniak, stated that the study, which has been relied on by Avandia’s maker GlaxoSmithKline, possessed serious flaws, the New York Times reports.
According to numerous reports and studies, taking Avandia might cause strokes and heart problems. The severity of its side effects has led the FDA to consider pulling the drug from shelves even though the drug already contains warnings about its dangers. We have previously reported on flaws in GlaxoSmithKline’s trials as well as the financial ties of their supporters.
Dangerous drugs, such as Avandia, can be responsible for injuries and even death. When an unreasonably dangerous or defective drug injures consumers those injured may have legal claims against the manufacturer and could be compensated for their losses. Lawyers call this area of the law products liability.
Consulting an experienced products liability attorney is usually easy and can help you determine if you have a case.
This consumer protection information is provided by Louisville, Kentucky attorney Will Nefzger, a partner at Bahe Cook Cantley & Jones PLC. Please feel free to contact me directly for if you have any questions or would like more information. Just click here, and it will take you to a page containing biographical and contact information and here to e-mail Will directly. As always, we will keep you updated as developments with Avandia and other potentially dangerous drugs or products occur.
